🇺🇸 FDA
Patent

US 8871905

Modification of CXCR4 using engineered zinc finger proteins

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 8871905 (Modification of CXCR4 using engineered zinc finger proteins) held by Sangamo Biosciences, Inc. expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K40/11, A61K40/46